In addition to the Drug Resistance Mutations Chart, the IAS–USA has many resources related to HIV drug-resistant mutations.

Related Webinars

Clinical Relevance of M184I/V in Current and Future HIV Management

Presenters: Charlotte Charpentier, PharmD; Roger Paredes, MD, PhD; Annemarie M. Wensing, MD, PhD
September 22, 2025
10:00 AM – 11:30 AM PT

The 2025 Update of the Drug Resistance Mutations in HIV-1: Review and Clinical Applications

Panelists: Roger Paredes, MD, PhD, Robert W. Shafer, MD, Francesca Ceccherini Silberstein, PhD
March 26, 2025
10:00 AM – 11:30 AM PT

Basic Principles and Clinical Relevance of the IAS–USA 2022 Update of the Drug Resistance Mutations in HIV-1

Moderator: Douglas D. Richman, MD
January 31, 2024
9:00 AM – 10:30 AM PT

Basics of HIV Drug Resistance Mutations

December 14, 2022
10:00 AM – 11:30 AM

HIV Drug Resistance: The 4th Decade

December 8, 2020
11:00 AM – 12:15 PM

Journal Articles

Current Evidence on Islatravir Drug Resistance and Implications for Future HIV Treatment

2026 Brief Communication

Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistances – Recommendations from IAS–USA panels

2025 Recommendations From Drug Resistance Group Mutations

2025 Update of the Drug Resistance Mutations in HIV-1

Erratum: 2025 Update of the Drug Resistance Mutations in HIV-1